Comparative analysis of methods used in the estimation of the sensitivity of Candida species to antifungal drugs;Analiza porównawcza metod stosowanych w ocenie wrażliwości grzybów z rodzaju Candida na leki przeciwgrzybicze

Mikologia Lekarska

Volumn 9, Issue 2, 2002, Pages 83-92

  Budak, Alicja ^a   Zwolińska Wcisło, Małgorzata ^a   Buckal, Anna ^a   Trojanowska, Danuta ^a   Bogusz, Bozena ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Antifungal drugs; Comparison of the methods; Sensitivity in vitro; Yeast like fungi

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; FLUCYTOSINE; KETOCONAZOLE;

ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA TROPICALIS; CONTROLLED STUDY; DIFFUSION; DILUTION; DRUG SENSITIVITY; IN VITRO STUDY; INTERMETHOD COMPARISON; LABORATORY TEST; NONHUMAN; SPECIES DIFFERENCE;

EID: 0036378927     PISSN: 1232986X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Morschhauser J.G., Blum-Oehler J.: Virulenz und resistenz Mechanismen pathogener Candida Species. Med. Welt., 1997, 48, 352-357.
2. Pawlik B., Macura A.B.: Diagnostyka laboratoryjna w mikologii. [w:] Zarys mikologii lekarskiej. red. E. Baran. Volumed, Wrocław 1998, 541-574.
3. Kremery V. Jr: Emerging fungal infections in cancer patients. J. Hosp. Inf., 1996, 33, 109-117.
4. Marichal P.J., Gorrens M.C., Coene, Le Jeune L., Van den Bossche H.: Origin of differences in susceptibility of Candida krusei to azo/e antifungal agents. Mycoses, 1995, 38, 111-117.
5. Morace G., Sanguinetti M., Posterado B., Paaagano L.: In vitro susceptibility of Candida species isolated from patients with hematological malignancies. Mycoses, 1995, 38, 59-67.
6. Rex J.H., Rinaldi M.G., Pfaller M.A.: Resistance of Candida species to fluconazole. Antimicrob. Agents Chemother., 1995, 39, 1-8.
7. Swoboda-Kopeċ E., Krajewska B., Sulik M., Łuczak M.: Oporność klinicznych izolatów Candida na leki przeciwgrzybicze. Medycyna Praktyczna, Zakażenia, 1998, 33-34.
8. Vant Wout J.W.: Fluconazole treatment of candidal infections caused by non-albicans species. Eur. J. Clin. Microbiol. Infect. Dis., 1996, 15, 232-238.
9. Barry A.L., Brown S.D.: Fluconazole disc diffusion procedure for determining susceptibility of Candida species. J. Clin. Microbiol., 1996, 34, 2154-2157.
10. Kwaśniewska J., Kumatowski P.: Wstȩpna ocena mikrotestu ATB-Fungus w badaniach wrażliwości na leki przeciwgrzybicze szczepów Candida. Mikol. Lek., 1995, 2, 201-203.
11. Ramani R., Ramani A., Kionk S.J.: Rapid flow cytometric susceptibility testing of Candida albicans. J. Clin. Microbiol., 1997, 35, 2320-2324.
12. Seibold M.: The Etest an alternative to the NCCLS standard for susceptibility testing of yeasts? Mycoses, 1996, 39, 44-46.
13. Canton E., Perman A., Carillo-Munoz, Orero A., Viudes A., Gobernado M.: Fluconazole susceptibilities of bloodstream Candida species isolates as determined by National Committee for Clinical Laboratory Standards Method M. 27-A and two other methods. J. Clin. Microbiol., 1999, 37, 2197-2200.
14. Metger S., Jarger H., Hofmann H.: In vitro susceptibility of Candida species to fluconazole by microdilution test and agar diffusion test. Mycoses, 1994, 37, 64-70.
15. Sanchez A.G., Rerez J.R., Carollo-Munoz A.J., Anaya J., Gil M.C., Hermosp J., De Mendoza J.M., Rodrigez A.: In vitro antifungal susceptibility testing on veterinary clinical isolates of yeasts. Mikol. Lek., 1996, 3, 239-242.
16. Schmalreck A.F., Kottmann I., Reiser A., Reiser U., Ruffer U., Vanca E.: Susceptibility testing of yeasts against fluconazole, comparison of the Etest method with microdilution and agar dilution. Mycoses, 1996, 39, 31-38.
17. Ruhnke M., Schmidt-Westhausen A., Engelmann E., Trautmann M.: Comparative evaluation of three antifungal susceptibility test methods for Candida albicans isolates and correlation with response to fluconazole therapy. J. Clin. Microbiol., 1996, 34, 3208-3211.
18. Cormican M.G., Pfaller M.A.: Standardization of antifungal susceptibility testing. J. Antimicrob. Chemother., 1996, 38, 561-578.
19. Da̧bkowska M., Garczewska B., Dzierżanowska D.: Lekowrażliwość szczepów Candida oceniona mikrotestem ATB-Fungus firmybio-Mérieux. Mikol. Lek., 1998, 5, 5-7.
20. Swinne D., Raes-Wuytack C., Van Looveren K., Desmet P.: Comparative evaluation of Fungitest, Neo-sensitabs and M-27T NCCLS microdilution methods for antifungal drug susceptibility testing of Candida species and Cryptococcus neoformans. Mycoses, 1999, 42, 232-237.